SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

30 May 2024 14:55

RNS Number : 4552Q
Caledonia Investments PLC
30 May 2024
Β 

Caledonia Investments plc

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

Β 

Pursuant to the requirements of the Market Abuse Regulation, Caledonia Investments plc ("Caledonia" or the "Company") announces that on 28 May 2024 the following nil-cost options over ordinary 5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2020 Performance Share Scheme (the "PSS") and in respect of compulsory deferral of bonus under the Caledonia Investments 2020 Deferred Bonus Plan (the "DBP"). The Company's share price used to determine the number of PSS awards and DBP awards was 3410p.

Β 

Executive Director

No. of shares over which PSS nil-cost options granted

No. of shares over which DBP nil-cost options granted

J M B Cayzer-Colvin

17,617

1,214

M S D Masters

21,620

2,979

R W Memmott

19,223

Nil

Subject to the rules of the PSS, nil-cost options are exercisable between three and ten years after the date of grant. Performance is measured over three years for one-third of the PSS awards which are subject to a post-vesting holding period, on an after-tax basis, of two years. The remaining two-thirds of the awards are subject to performance over five years.

Subject to the rules of the DBP, deferred share awards vest after a three-year retention period.

Β 

The total number of shares held under option by the above-named executive directors of Caledonia under the Company's performance share schemes following these nil-cost option grants are as follows:

Β 

Executive Director

Total no. of shares held under option under PSS

Total no. of shares held under option under DBP

J M B Cayzer-Colvin

97,000

10,311

M S D Masters

92,377

11,442

R W Memmott

36,796

Nil

Β 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Β 

Enquiries:

Richard Webster

Company Secretary

Tel: + 44 20 7802 8080

Β 

30 May 2024

Β 

Β 

APPENDIX

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

James Michael Beale Cayzer-Colvin

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Executive Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost options over ordinary 5p shares under:

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

Β 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Description

Price(s)

Β 

Volume(s)

Grant of PSS award

Β 

Β£0.00

Β 

17,617

Grant of DBP award

Β 

Β£0.00

1,214

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

18,831

Β 

Nil

e)

Β 

Date of the transaction

Β 

28 May 2024

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Mathew Simon Dexter Masters

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Director/Chief Executive Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost options over ordinary 5p shares under:

Β 

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

Β 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Description

Price(s)

Β 

Volume(s)

Grant of PSS award

Β 

Β£0.00

Β 

21,620

Grant of DBP award

Β 

Β£0.00

2,979

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

24,599

Β 

Nil

e)

Β 

Date of the transaction

Β 

28 May 2024

f)

Place of the transaction

Outside a trading venue

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Robert William Memmott

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Executive Director/Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost options over ordinary 5p shares under the Caledonia Investments 2020 Performance Share Scheme ("PSS")

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Description

Price(s)

Β 

Volume(s)

Grant of PSS award

Β 

Β£0.00

Β 

19,223

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

n/a

Β 

n/a

e)

Β 

Date of the transaction

Β 

28 May 2024

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBXGDUXUXDGSG
Date   Source Headline
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report
5th Jun 20209:05 amRNSNet Asset Value(s)
1st Jun 20205:20 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSFinal Results
19th May 20205:28 pmRNSDirector Declaration
7th May 20209:08 amRNSNet Asset Value(s)
30th Apr 20204:26 pmRNSDirector Declaration
28th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20206:06 pmRNSDisclosure of rights attached to equity shares
7th Apr 20207:00 amRNSNet Asset Value(s)
30th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 20204:41 pmRNSPrice Monitoring Extension
20th Mar 202010:10 amRNSHolding(s) in Company
5th Mar 202011:24 amRNSNet Asset Value(s)
6th Feb 202010:47 amRNSNet Asset Value(s)
7th Jan 20209:53 amRNSNet Asset Value(s)
2nd Jan 20208:00 amRNSBlock listing Interim Review
20th Dec 20199:43 amRNSCompany Secretary Change
17th Dec 20198:05 amRNSDirector/PDMR Shareholding
6th Dec 201910:23 amRNSNet Asset Value(s)
28th Nov 201910:05 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSHalf-year Report
22nd Nov 20193:40 pmRNSDirector Declaration
7th Nov 20199:13 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.